NASDAQ:NARI Inari Medical (NARI) Stock Price, News & Analysis $53.83 -1.37 (-2.48%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$53.77▼$56.1050-Day Range$43.23▼$58.6252-Week Range$36.73▼$71.85Volume1.05 million shsAverage Volume1.03 million shsMarket Capitalization$3.13 billionP/E RatioN/ADividend YieldN/APrice Target$64.83 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Inari Medical alerts: Email Address Inari Medical MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.57 Rating ScoreUpside/Downside20.4% Upside$64.83 Price TargetShort InterestBearish8.94% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.92Based on 13 Articles This WeekInsider TradingSelling Shares$13.11 M Sold Last QuarterProj. Earnings GrowthGrowingFrom ($0.41) to $0.20 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.39 out of 5 starsMedical Sector612th out of 936 stocksSurgical & Medical Instruments Industry74th out of 101 stocks 3.3 Analyst's Opinion Consensus RatingInari Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.57, and is based on 4 buy ratings, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageInari Medical has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Inari Medical's stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted8.94% of the outstanding shares of Inari Medical have been sold short.Short Interest Ratio / Days to CoverInari Medical has a short interest ratio ("days to cover") of 5.6.Change versus previous monthShort interest in Inari Medical has recently increased by 11.59%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldInari Medical does not currently pay a dividend.Dividend GrowthInari Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for NARI. Previous Next 3.3 News and Social Media Coverage News SentimentInari Medical has a news sentiment score of 0.92. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 13 news articles for Inari Medical this week, compared to 8 articles on an average week.MarketBeat Follows5 people have added Inari Medical to their MarketBeat watchlist in the last 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Inari Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $13,113,558.00 in company stock.Percentage Held by Insiders10.60% of the stock of Inari Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions90.98% of the stock of Inari Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Inari Medical's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Inari Medical are expected to grow in the coming year, from ($0.41) to $0.20 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Inari Medical is -131.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Inari Medical is -131.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioInari Medical has a P/B Ratio of 6.67. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Inari Medical's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad American Hartford Gold GroupPrepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.GET THE FREE GUIDE About Inari Medical Stock (NASDAQ:NARI)Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.Read More NARI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NARI Stock News HeadlinesJuly 25 at 6:34 AM | insidertrades.comInsider Selling: Inari Medical, Inc. (NASDAQ:NARI) CEO Sells 3,000 Shares of StockJuly 19, 2024 | insidertrades.comInari Medical, Inc. (NASDAQ:NARI) Director Sells $3,404,400.00 in StockJuly 26, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.July 17, 2024 | insidertrades.comInsider Selling: Inari Medical, Inc. (NASDAQ:NARI) CFO Sells 5,000 Shares of StockJuly 4, 2024 | insidertrades.comInari Medical, Inc. (NASDAQ:NARI) CEO Sells $150,240.00 in StockJuly 4, 2024 | insidertrades.comInari Medical, Inc. (NASDAQ:NARI) Director William Hoffman Sells 20,000 SharesJuly 25 at 7:24 AM | americanbankingnews.comInari Medical (NASDAQ:NARI) Earns Outperform Rating from Analysts at William BlairJuly 20, 2024 | americanbankingnews.comInari Medical (NASDAQ:NARI) Shares Gap Down Following Insider SellingJuly 26, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.July 19, 2024 | finance.yahoo.comInsider Sale: Chief Medical Officer Thomas Tu Sells Shares of Inari Medical Inc (NARI)July 19, 2024 | msn.comNeedham Downgrades Inari Medical (NARI)July 18, 2024 | americanbankingnews.comNeedham & Company LLC Lowers Inari Medical (NASDAQ:NARI) to HoldJuly 18, 2024 | americanbankingnews.comInsider Selling: Inari Medical, Inc. (NASDAQ:NARI) Insider Sells 16,520 Shares of StockJuly 17, 2024 | americanbankingnews.comInari Medical (NASDAQ:NARI) Price Target Increased to $60.00 by Analysts at Truist FinancialJuly 16, 2024 | globenewswire.comInari Medical to Announce Second Quarter 2024 Financial ResultsJuly 16, 2024 | americanbankingnews.comInari Medical, Inc. (NASDAQ:NARI) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesJuly 12, 2024 | globenewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Inari Medical, Inc. – NARIJuly 12, 2024 | globenewswire.comNARI Investors Have Opportunity to Lead Inari Medical, Inc. Securities Fraud Lawsuit with the Schall Law FirmSee More Headlines Receive NARI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Inari Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/30/2024Today7/26/2024Next Earnings (Confirmed)7/30/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:NARI CUSIPN/A CIK1531048 Webwww.inarimedical.com Phone877-923-4747FaxN/AEmployees1,300Year FoundedN/APrice Target and Rating Average Stock Price Target$64.83 High Stock Price Target$84.00 Low Stock Price Target$50.00 Potential Upside/Downside+20.4%Consensus RatingModerate Buy Rating Score (0-4)2.57 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)($0.41) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-1,640,000.00 Net Margins-4.54% Pretax Margin-2.04% Return on Equity-1.65% Return on Assets-1.23% Debt Debt-to-Equity RatioN/A Current Ratio2.71 Quick Ratio2.19 Sales & Book Value Annual Sales$493.63 million Price / Sales6.34 Cash Flow$0.09 per share Price / Cash Flow628.19 Book Value$8.07 per share Price / Book6.67Miscellaneous Outstanding Shares58,140,000Free Float51,975,000Market Cap$3.13 billion OptionableOptionable Beta1.01 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. Andrew J. Hykes (Age 51)CEO, President & Director Comp: $1.54MMr. Mitchell C. Hill (Age 65)Chief Financial Officer Comp: $864.63kDr. Thomas M. Tu M.D. (Age 51)Chief Medical Officer Comp: $865.63kMr. Paul A. Koehn (Age 61)Senior Vice President of Operations Mr. Kevin StrangeSenior Vice President of Finance, Accounting, Strategy & Business DevelopmentMr. John Hsu C.F.A.Vice President of Investor RelationsMs. Angela AhmadGeneral Counsel & SecretaryMr. Eric KhairySenior Vice President of MarketingMr. Tim BennerSenior VP of Sales & Senior VP of U.S. SalesMs. Tara DunnSenior VP & GM of LimFlowMore ExecutivesKey CompetitorsICU MedicalNASDAQ:ICUICantel MedicalNYSE:CMDNuVasiveNASDAQ:NUVAMerit Medical SystemsNASDAQ:MMSIGlaukosNYSE:GKOSView All CompetitorsInsiders & InstitutionsBank of New York Mellon CorpSold 26,092 shares on 7/26/2024Ownership: 0.668%AlphaCentric Advisors LLCSold 48,000 shares on 7/26/2024Ownership: 0.026%Legato Capital Management LLCBought 8,235 shares on 7/26/2024Ownership: 0.014%Louisiana State Employees Retirement SystemBought 600 shares on 7/24/2024Ownership: 0.045%Andrew HykesSold 3,000 sharesTotal: $165,690.00 ($55.23/share)View All Insider TransactionsView All Institutional Transactions NARI Stock Analysis - Frequently Asked Questions How have NARI shares performed this year? Inari Medical's stock was trading at $64.92 at the start of the year. Since then, NARI stock has decreased by 17.1% and is now trading at $53.83. View the best growth stocks for 2024 here. How were Inari Medical's earnings last quarter? Inari Medical, Inc. (NASDAQ:NARI) issued its quarterly earnings results on Tuesday, April, 30th. The company reported ($0.26) earnings per share for the quarter, missing the consensus estimate of ($0.11) by $0.15. The company earned $143.19 million during the quarter, compared to the consensus estimate of $138.32 million. Inari Medical had a negative trailing twelve-month return on equity of 1.65% and a negative net margin of 4.54%. When did Inari Medical IPO? Inari Medical (NARI) raised $110 million in an initial public offering (IPO) on Friday, May 22nd 2020. The company issued 7,300,000 shares at $14.00-$16.00 per share. BofA Securities and Morgan Stanley served as the underwriters for the IPO and Canaccord Genuity and Wells Fargo Securities were co-managers. Who are Inari Medical's major shareholders? Top institutional investors of Inari Medical include Bank of New York Mellon Corp (0.67%), Louisiana State Employees Retirement System (0.04%), AlphaCentric Advisors LLC (0.03%) and Legato Capital Management LLC (0.01%). Insiders that own company stock include Donald B Milder, William Hoffman, Andrew Hykes, Thomas Tu and Mitch C Hill. View institutional ownership trends. How do I buy shares of Inari Medical? Shares of NARI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Inari Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Inari Medical investors own include NVIDIA (NVDA), Home Depot (HD), CVS Health (CVS), QUALCOMM (QCOM), Thermo Fisher Scientific (TMO) and Johnson & Johnson (JNJ). This page (NASDAQ:NARI) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inari Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inari Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NARI Stock Alerts